Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1

Overview of attention for article published in Nature Genetics, May 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

So far, Altmetric has seen 20 X posts from 13 X users, with an upper bound of 114,536 followers.

RT @obahcall: Mefford et al report de novo mutations in CHD2 and SYNGAP1 as a cause of epileptic encephalopathy #NatGen http://t.co/MEFWSrM…

RT @DDG2P: SYNGAP1; Confirmed DD Gene; 13585; epileptic encephalopathy; Monoallelic; Loss of function; http://t.co/EnoC5lkgmE

RT @obahcall: Mefford et al report de novo mutations in CHD2 and SYNGAP1 as a cause of epileptic encephalopathy #NatGen http://t.co/MEFWSrM…

RT @WiringTheBrain: Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1 http://t.co/kbiKbo…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 16 additional X posts.